Vanda Pharmaceuticals Inc <VNDA.O>: Oppenheimer initiates coverage with outperform rating; price target $10
VNDA•Related News
Collegium Pharmaceutical, Inc. <COLL.O>: Oppenheimer Initiates Coverage With Outperform Rating; Price Target $50
COLL•
Quanome signs US$18.8 million deal to buy NVIDIA-powered AI computing infrastructure
QNME•
Marsh playbook warns insurability hinges on place-based climate resilience amid $145 billion 2025 insured catastrophe losses
MMC•
Wearable Devices wins China patent allowance for pressure-based gesture control
WLDS•
eHealth partners with BerniePortal to offer integrated CHOICE benefits for employers
EHTH•